Expression of Circulating MicroRNAs and Myokines and Interactions with Serum Osteopontin in Type 2 Diabetic Patients with Moderate and Poor Glycemic Control: A Biochemical and Molecular Study

Table 1

The demographics, clinical, and metabolic characteristics of the participants.

Variables	Type 2 diabetes ()
	Moderate glycemic control (>7-8% HbA1c, )	Poor glycemic control (>8% HbA1c, )
Genders (male/female)	18/12	29/21
Age (years)
BMI (kg/m^2)
Fat-free mass (kg)
Fat mass (kg)
Fasting plasma glucose (mmol L^-1)		^b
HbA1c (%)		^c
FINS (mUI/mL)		^c
HOMA-IR		^b
Diabetes duration (years)

Values are expressed as ; significance at ^a, ^b, and ^c. Abbreviations: BMI: body mass index; HOMA: homeostatic model assessment; IR: insulin resistance; FINS: fasting serum insulin; HbA1c: glycated hemoglobin A1c.